Altamira Therapeutics Ltd. ( CYTO) - Stock Earnings

CYTO Quarterly earnings

DateEarningsRevenue
2022Q1 -3.7 million USD 611499 USD
2022Q2 -3.7 million USD 611499 USD
2023Q2 -6.6 million USD 128631 USD

CYTO Yearly earnings

DateEarningsRevenue
2020 -9.1 million USD 194228 USD
2021 -19.1 million USD 70053 USD
2022 -28.7 million USD 330548 USD

CYTO

Price: $0.30

52 week price:
0.30
7.38

Earnings Per Share: 1.82 USD

P/E Ratio: 0.28

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: Bermuda

Volume: 22400

Market Capitalization: 2.0 million

Links: